These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Value of the analysis of DNA cellular content by flow cytometry in Barrett esophagus]. Robaszkiewicz M; Hardy E; Volant A Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D35-9. PubMed ID: 8013781 [No Abstract] [Full Text] [Related]
6. Molecular basis of esophageal cancer development and progression. Denlinger CE; Thompson RK Surg Clin North Am; 2012 Oct; 92(5):1089-103. PubMed ID: 23026271 [TBL] [Abstract][Full Text] [Related]
7. Barrett's esophagus: the long and the short of it. Lewis JD Gastroenterology; 2000 Oct; 119(4):1165-6. PubMed ID: 11040204 [No Abstract] [Full Text] [Related]
8. Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides. Normanno N; Bianco C; Damiano V; de Angelis E; Selvam MP; Grassi M; Magliulo G; Tortora G; Bianco AR; Mendelsohn J; Salomon DS; Ciardiello F Clin Cancer Res; 1996 Mar; 2(3):601-9. PubMed ID: 9816209 [TBL] [Abstract][Full Text] [Related]
10. APC gene alterations in Barrett's metaplasia are implicated at an early stage in the carcinogenesis of esophageal adenocarcinoma. Fein M Am J Gastroenterol; 1997 Feb; 92(2):359-60. PubMed ID: 9040229 [No Abstract] [Full Text] [Related]
11. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. Jankowski J; Hopwood D; Pringle R; Wormsley KG Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848 [TBL] [Abstract][Full Text] [Related]
12. Nonmitogenic actions of growth factors: an integrated view of their role in intestinal physiology and pathophysiology. Uribe JM; Barrett KE Gastroenterology; 1997 Jan; 112(1):255-68. PubMed ID: 8978367 [No Abstract] [Full Text] [Related]
13. [From Barrett esophagus to adenocarcinoma: can the dangers of natural history be overcome?]. Robaszkiewicz M Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B89-97. PubMed ID: 8761127 [No Abstract] [Full Text] [Related]
14. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis. von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis. Yacoub L; Goldman H; Odze RD Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Tørring N; Jørgensen PE; Sørensen BS; Nexø E Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639 [TBL] [Abstract][Full Text] [Related]
18. What are the real roles of different erbB proteins in Barrett's Esophagus. Chiba T Digestion; 2004; 70(2):93-4. PubMed ID: 15375337 [No Abstract] [Full Text] [Related]
19. [New approaches to antitumor therapy: the use of preparations acting on processes regulated by epidermal and/or alpha-transforming growth factors]. Kushlinskiĭ NE; Gershteĭn ES Eksp Klin Farmakol; 1996; 59(1):74-80. PubMed ID: 8704642 [No Abstract] [Full Text] [Related]
20. Roles of transforming growth factor-alpha and epidermal growth factor in chick limb development. Dealy CN; Scranton V; Cheng HC Dev Biol; 1998 Oct; 202(1):43-55. PubMed ID: 9758702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]